Home > Analytics > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Intrinsic Value | Fundamental Analysis

BOM : 537291     NSE : NATHBIOGEN    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Average [Stock is fairly valued]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : None or < 25%
Sep 27,2022
Price(EOD): ₹ 160.30
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Agriculture
MCap: ₹ 304.57 Cr
Value of ₹ 1 Lac invested in NATH BIOGENES (INDIA)
on Sep 27,2017 (price: ₹ 365.40)

₹ 1 L

₹ 0.44 L

1W : -8.4% 1M : -18.1% 1Y : -51.3%
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
NATH BIOGENES (INDIA) -8.4% -18.1% -51.3%
BOMBAY BURMAH TRADING CORPORATION -4.2% 2% -21.3%
VENKYS (INDIA) -3.9% -4.3% -33.2%
KAVERI SEED COMPANY -5.5% -6.8% -25.1%
HARRISONS MALAYALAM -8.6% -12.9% -26%
JK AGRI GENETICS -1.2% -1.7% -30.3%
BOMBAY SUPER HYBRID SEEDS 21.4% 119.4% 223.5%
SHREE GANESH BIOTECH (INDIA) -4.7% -16.9% -74.2%
MANGALAM GLOBAL ENTERPRISE -17.8% -23.6% 232.7%

FUNDAMENTAL ANALYSIS OF NATH BIOGENES (INDIA)

 
Fundamentals Score
[ Q(TTM): Jun2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF NATH BIOGENES (INDIA)

 
Valuation Score
[As on : Sep 27,2022 ]

Ratio Standalone
P/E
P/B
P/S
-3.74
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -81.49 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

0.56
P/B Calculated based on Book Value of Rs 541.97 Cr
[Latest Year - Mar2022 - Standalone Results ]

1.11
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2022 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 17% undervalued companies ! Discover More →

FAIR VALUE OF NATH BIOGENES (INDIA)

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-2%
19%
-7%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF NATH BIOGENES (INDIA)



NATH BIOGENES (INDIA) vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF NATH BIOGENES (INDIA)

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0.17
0.16
0.13
0.15
-
-
-
-
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF NATH BIOGENES (INDIA)

Pledged Promoter Shares
9.34 %
As on : Jun2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF NATH BIOGENES (INDIA)

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
649.48%
267.97%
127.41%
126.45%
-2.66%
-28.95%
-31.58%
-31.52%
QtrlyTrend
0
Latest Qtr: Jun2022
Quarterly Result Analysis →


NATH BIOGENES (INDIA) related INDICES

BSE Indices1W1M1Y
S&P BSE FMCG 0.2% 3.2% 5.5%
S&P BSE ALLCAP -4.8% -2.4% -1.2%
S&P BSE SMALL CAP -4.9% -1.2% 0.5%
S&P BSE MIDSMALLCAP -5.1% -1.5% -0.9%
No NSE index found

You may also like the below Video Courses


FAQ about NATH BIOGENES (INDIA)


Is NATH BIOGENES (INDIA) good for long term investment?

As on Sep 27,2022, the Fundamentals of NATH BIOGENES (INDIA) look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NATH BIOGENES (INDIA) . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NATH BIOGENES (INDIA) UnderValued or OverValued?

As on Sep 27,2022, NATH BIOGENES (INDIA) is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!

What is the Intrinsic Value of NATH BIOGENES (INDIA) ?

As on Sep 27,2022, the Intrinsic Value of NATH BIOGENES (INDIA) is Rs. 163.76 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 163.76
Fair Value [Median EV / Sales Model] : Rs. 134.87
Fair Value [Median Price / Sales Model] : Rs. 172.95
Estimated Median Fair Value of NATH BIOGENES (INDIA) : Rs. 163.76

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is NATH BIOGENES (INDIA) trading at a Premium or Discount?

As on Sep 27,2022, NATH BIOGENES (INDIA) is trading at a Discount of -2% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].